Cargando…
Chitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitus
PURPOSE: As a potential protein therapeutic for type 2 diabetes mellitus (T2DM), BAY 55-9837 is limited by poor stability and a very short half-life in vivo. The purpose of this study was to construct a novel nanostructured biomaterial by conjugating BAY 55-9837 to chitosan-decorated selenium nanopa...
Autores principales: | Rao, Lei, Ma, Yi, Zhuang, Manjiao, Luo, Tianjie, Wang, Yayu, Hong, An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207575/ https://www.ncbi.nlm.nih.gov/pubmed/25378923 http://dx.doi.org/10.2147/IJN.S67871 |
Ejemplares similares
-
VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models
por: Hadwen, Jeremiah, et al.
Publicado: (2014) -
Islet protection and amelioration of type 2 diabetes mellitus by treatment with quercetin from the flowers of Edgeworthia gardneri
por: Zhuang, Manjiao, et al.
Publicado: (2018) -
Immunomodulatory Effects Mediated by Nano Amorphous Calcium Phosphate/Chitosan Oligosaccharide Lactate Coatings Decorated with Selenium on Titanium Implants
por: Pantović Pavlović, Marijana R., et al.
Publicado: (2023) -
An Electroconductive, Thermosensitive, and Injectable Chitosan/Pluronic/Gold-Decorated Cellulose Nanofiber Hydrogel as an Efficient Carrier for Regeneration of Cardiac Tissue
por: Tohidi, Hajar, et al.
Publicado: (2022) -
Nanostructured Lipid Carriers (NLCs) for Oral Peptide Drug Delivery: About the Impact of Surface Decoration
por: Shahzadi, Iram, et al.
Publicado: (2021)